Neonc Technologies, Inc.
4 clinical trials · Sponsor
◉ Watch Neonc Technologies, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors (NCT06357377) | Neonc Technologies, Inc. | 2026-01-01 |
| NEO100 and High-Grade Meningioma (NCT05023018) | Neonc Technologies, Inc. | 2022-07-01 |
Track Neonc Technologies, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.